COVID-19 may become nanomedicine’s finest hour yet
Source abstract
Abstract
The nanotechnology-enabled mRNA-based vaccine platform recently approved against COVID-19 bears hope for improved vaccine development and trialling capacities in low- and middle-income countries as part of a broader global public health agenda.
The source flagged this abstract for review. Check formulas and completeness against the original publication.
Source: openaire · Quality: needs review · Source record ↗
Source flags: short_text
Source flags: short_text
Research context
OpenAlex topics: SARS-CoV-2 and COVID-19 Research · SARS-CoV-2 detection and testing · Immune responses and vaccinations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (20)
Show source-provided references
1. Covid-19 data in motion: Thursday, 4 March. John Hopkins Coronavirus Resource Center https://coronavirus.jhu.edu (2021).
2. Impact of the coronavirus pandemic on the global economy - statistics & facts. Stastista Research Department https://www.statista.com/topics/6139/covid-19-impact-on-the-global-economy/ (2021).
3. Owen, R. & Pansera, M. in Handbook on Science and Public Policy (eds Simon, D. et al.) 20–48 (Edward Elgar Publishing, 2019).
4. World Health Organization Status Of COVID-19 Vaccines Within WHO EUL/PQ Evaluation Process Guidance document (WHO, 2021); https://go.nature.com/38KrFiR
5. Nat. Nanotechnol. 15, 239–240 (2020).10.1038/s41565-020-0680-y ↗
6. Nat. Nanotechnol. 15, 617 (2020).10.1038/s41565-020-0757-7 ↗
7. Shin, M. D. et al. Nat. Nanotechnol. 15, 646–655 (2020).10.1038/s41565-020-0737-y ↗
8. Nat. Nanotechnol. 15, 963 (2020).10.1038/s41565-020-00820-0 ↗
9. Pardi, N. et al. Nat Rev Drug Discov 17, 261–279 (2018).10.1038/nrd.2017.243 ↗
10. Huang, L. et al. Asian J. Pharm. Sci. https://doi.org/10.1016/j.ajps.2020.08.001 (2020).10.1016/j.ajps.2020.08.001 ↗
11. Lurie, N., Saville, M., Hatchett, R. & Halton, J. N Engl. J. Med. 382, 1969–1973 (2020).10.1056/NEJMp2005630 ↗
12. Xiong, Q. et al. Nano Res. 11, 5281–5309 (2018).10.1007/s12274-018-2146-1 ↗
13. Jones, R. Nanomacines come of age with mRNA vaccine. Soft Machines http://go.nature.com/3cGud2F (2020).
14. Li, J., Zeng, M., Shan, H. & Tong, C. Curr Med Chem. 24, 2413–2422 (2017).
15. Moitra, P., Alafeef, M., Dighe, K., Frieman, M. B. & Pan, D. ACS Nano (2020).
16. An evaluation of the safety of Oncocort IV pegylated liposomal dexamethasone phosphate in patients with progressive multiple myeloma (AMETHYST). ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03033316 (2017).
17. Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 (University of Oxford, 2020); https://www.recoverytrial.net/files/recovery_dexamethasone_statement_160620_v2final.pdf (2020).
18. The top 10 causes of death. World Health Organization https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (2020).
19. Kawasaki, E. S. & Player, A. Nanomedicine 1, 101–109 (2005).10.1016/j.nano.2005.03.002 ↗
20. Current nanotechnology treatments. National Cancer Institute https://www.cancer.gov/nano/cancer-nanotechnology/current-treatments (2017).